4.5 Article

Preoperative sST2 levels relate to myocardial remodeling and cardiac function improvement after cardiac valve surgery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Value of Fast MVO Identification From Contrast-Enhanced Cine (CE-SSFP) Combined With Myocardial Strain in Predicting Adverse Events in Patients After ST-Elevation Myocardial Infarction

Min Zhang et al.

Summary: Identification of microvascular occlusion from contrast-enhanced steady-state free precession (CE-SSFP) combined with myocardial strain analysis can provide a quick and reliable option for predicting major cardiovascular adverse events (MACEs) in primary percutaneous coronary intervention (pPCI) patients with ST-elevation myocardial infarction (STEMI).

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Anesthesiology

Cardiac Biomarkers and Prediction of Early Outcome After Heart Valve Surgery: A Prospective Observational Study

Aaron Wozolek et al.

Summary: Cardiac biomarkers may have the potential to predict long-term outcomes after cardiac surgery, but their ability to predict short-term morbidity appears limited.

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)

Review Biology

B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?

Toshio Nishikimi et al.

Summary: BNP and proBNP are useful biomarkers for heart failure, and measuring plasma BNP levels is important for the diagnosis and assessment of heart disease. During ARNI treatment, there may be a mild increase in BNP levels initially, but later there is a reduction in BNP due to the decrease in myocardial wall stress.

BIOLOGY-BASEL (2022)

Article Cardiac & Cardiovascular Systems

Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery

Dipal M. Patel et al.

AMERICAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

Sandra Crnko et al.

ESC HEART FAILURE (2020)

Review Medical Laboratory Technology

Soluble ST2: A complex and diverse role in several diseases

Evgenija Homsak et al.

CLINICA CHIMICA ACTA (2020)

Review Biochemistry & Molecular Biology

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine

Zhipeng Cao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Urology & Nephrology

Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure

Xavier Charmetant et al.

CLINICAL NEPHROLOGY (2019)

Article Biotechnology & Applied Microbiology

sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting

Meagan E. Stabler et al.

BIOMARKERS (2019)

Review Cardiac & Cardiovascular Systems

Soluble ST2 in Heart Failure

Cian P. McCarthy et al.

HEART FAILURE CLINICS (2018)

Article Cardiac & Cardiovascular Systems

2017 ESC/EACTS Guidelines for the management of valvular heart disease

Volkmar Falk et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)

Article Cardiac & Cardiovascular Systems

ST2 predicts survival in patients undergoing transcatheter aortic valve implantation

Johannes Schmid et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Medicine, General & Internal

Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015

David A. Watkins et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective

William S. Jenkins et al.

AMERICAN JOURNAL OF MEDICINE (2017)

Article Anesthesiology

Outcome of cardiac surgery in patients with low preoperative ejection fraction

Marina Pieri et al.

BMC ANESTHESIOLOGY (2016)

Review Biochemistry & Molecular Biology

The IL-33/ST2 axis: Role in health and disease

Marjorie De la Fuente et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2015)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Soluble ST2 in the Valsartan Heart Failure Trial

Inder S. Anand et al.

CIRCULATION-HEART FAILURE (2014)

Article Cardiac & Cardiovascular Systems

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

John Gordon Harold et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Guidelines on the management of valvular heart disease (version 2012)

Alec Vahanian et al.

EUROPEAN HEART JOURNAL (2012)

Article Cardiac & Cardiovascular Systems

Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction

Robin A. P. Weir et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling

Kenjiro Seki et al.

CIRCULATION-HEART FAILURE (2009)